The role of omega-3 fatty acids in renal disorders

Journal of the American Veterinary Medical Association

Volumn 209, Issue 5, 1996, Pages 906-910

  Plotnick, A N ^a,b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; FISH OIL; OMEGA 3 FATTY ACID;

DOG; DRUG EFFECT; DRUG MECHANISM; GLOMERULONEPHRITIS; HEMOSTASIS; HYPERTENSION; ICOSANOID METABOLISM; KIDNEY DISEASE; LIPID BLOOD LEVEL; NONHUMAN; REVIEW;

ANIMAL DISEASES; ANIMALS; DOGS; FATTY ACIDS, OMEGA-3; GUINEA PIGS; HUMANS; KIDNEY DISEASES; RABBITS; RATS;

CANIS FAMILIARIS;

EID: 0029811109     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Moorehead JF, Chan MK, Varghese Z. The role of abnormalities of lipid metabolism in the progression of renal disease. In: Mitch WE, ed. The progressive nature of renal disease. New York: Churchill Livingstone Inc, 1986;133-148.
2. Grone H, Walli A, Grone E, et al. Induction of glomerulosclerosis by dietary lipids. Lab Invest 1989;60:433-446.
3. Bilo HJG. Omega-3 polyunsaturated fatty acids in chronic renal failure. Nephron 1988;57:385-393.
4. Ackerman L. Review of the biochemical properties of fatty acids. Vet Med 1995;90:1138-1147.
5. Exler J, Weihrauch JL. Comprehensive evaluation of fatty acids in food. J Am Diet Assoc 1976;69:243-248.
6. Brown SA. Dietary lipids and progressive renal disease in the dog in Proceedings. 16th Annu Waltham/The Ohio State University Symp (Nephrology and Urology) 1992;43-44.
7. De Caterina R, Endres S, Kristensen SD, et al. n-3 fatty acids and renal diseases. Am J Kidney Dis 1994;23:3:397-415.
8. Brown SA. Dietary fatty acid supplementation and chronic renal disease, in Proceedings. 13th Am Coll Vet Intern Med Forum 1995;470-472.
9. Bagdade JD, Porte D Jr, Bierman EL. Hypertriglyceridemia, a metabolic consequence of chronic renal failure. N Engl J Med 1968; 279:181-185.
10. Kikuchi Y, Koyama T, Koyama Y, et al. Red cell deformability in renal failure. Nephron 1982;30:8-14.
11. Popp-Snijders C, Schouten JA, van Blitterswijk WJ, et al. Changes in the membrane lipid composition of human erythrocytes after dietary supplementation of (n-3) polyunsaturated fatty acids. Maintenance of membrane fluidity. Biochim Biophys Acta 1986;854: 31-36.
12. Grauer GF, Frisbie DD, Longhofer SL, et al. Effects of a thromboxane synthetase inhibitor on established immune complex glomerulonephritis in dogs. Am J Vet Res 1992;53:808-813.
13. Longhofer SL, Johnson HC, Culham CA, et al. Effects of a specific thromboxane synthetase inhibitor on thromboxane generation and excretion in healthy dogs. Am J Vet Res 1990;51:1746-1750.
14. Longhofer SL, Frisbie DD, Johnson HC, et al. Effects of thromboxane synthetase inhibition on immune complex glomerulonephrilis. Am J Vet Res 1991;52:480-487.
15. Alvestrand A, Gutierrez H, Bucht H, et al. Reduction of blood pressure retards the progression of chronic renal failure in man. Nephrol Dial Transplant 1988;3:624-631.
16. Hostetter TH, Olson JL, Rennke HG, et al. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1982;241:F85-F92.
17. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of renal disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982;307:652-659.
18. Heifets M, Morrissey JJ, Purkerson ML, et al. Effect of dietary lipids on renal function in rats with subtotal nephrectomy. Kidney Int 1987;32:335-341.
19. Brown SA, Finco DR, Choat D, et al. Single nephron adaptations to partial renal ablation in dogs. Am J Physiol 1990;258: F495-F503.
20. Brown SA, Finco DR, Crowell WA, et al. Dietary protein intake and the glomerular adaptations to partial nephrectomy in dogs. J Nutr 1991;121:S125-S127.
21. Norris PG, Jones CJH, Weston MJ. Effect of dietary supplementation with fish oil on systolic blood pressure in mild essential hypertension. BMJ 1986;293:104-105.
22. Knapp HR, Fitzgerald GA. The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N Engl J Med 1989;320:1037-1043.
23. Myers BD. Cyclosporin nephrotoxicity. Kidney Int 1986;30: 964-974.
24. Jevnikar AM, Petric R, Holub BJ, et al. Effect of cyclosporin therapy on plasma lipoprotein levels. J Am Med Assoc 1989;262:53-56.
25. Cohen H, Neild GH, Patel R, et al. Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporin-treated renal allograft recipients. Thromb Res 1988;49:91-101.
26. Stoof TJ, Korstanje MJ, Bilo HJG, et al. Does fish oil protect renal function in cyclosporin treated psoriasis patients? J Int Med 1989;226:437-441.
27. Homan van der Heide JJ, Bilo HJG, Tegsess AM, et al. The effect of dietary supplementation with fish oil on renal function in cyclosporin-treated renal transplant recipients. Transplantation 1990; 49:523-527.
28. 2 synthesis induced by cyclosporin A. Am J Physiol 1986;251:F581-F587.
29. Bennett WM, Elzinga L, Kelley VE. Pathophysiology of cyclosporin nephrotoxicity: role of eicosanoids. Transplant Proc 1988; 20:628-633.
30. Elzinga L, Kelley VE, Houghton DC. Fish oil vehicle for cyclosporin lowers renal thromboxanes and reduces experimental nephrotoxicity. Transplant Proc 1990;19:1403-1406.
31. Rogers TS, Elzinga L, Bennet WM, et al. Selective enhancement of thromboxane in macrophages and kidneys in cyclosporin-induced nephrotoxicity. Dietary protection by fish oil. Transplantation 1988;45:153-156.
32. Urakaze M, Hamazaki T, Kashiwabara H, et al. Favorable effects of fish oil concentrate on risk factors for thrombosis in renal allograft recipients. Nephron 1989;53:102-109.
33. Rylance BP, Jordge MP, Saynor R, et al. Fish oil in hemodialysis patients. Nephron 1986;43:196-202.
34. Zoja C, Benigni A, Remuzzi G. Role of eicosanoids as mediators of glomerular injury in immune-mediated nephropathies. Contrib Nephrol 1989;69:18-26.
35. Schlondorff D, Goldwasser P, Neuwirth R, et al. Production of platelet activating factor in glomeruli and cultured glomerular mesangial cells. Am J Physiol 1986;19:F1123-F1127.
36. Schreiner GF, Rovin B, Lefkowith JB. The anti-inflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis: the modulation of macrophage migration and eicosanoid metabolism. J Immunol 1989;143:3192-3199.
37. 1 hybrid mice fed an essential fatty acid-deficient diet. J Clin Invest 1981;67:476.
38. Kelley VE, Ferretti A, Izui S, et al. A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites and suppresses lupus in MRL-lpr mice. J Immunol 1985;134:1914.
39. Ito Y, Barcelli U, Yamashita W, et al. Fish oil has beneficial effects on lipids and renal disease of nephrotic rats. Metabolism 1988; 37:352-357.
40. Scharschmidt LA, Gibbons NB, McGarry L, et al. Effects of dietary fish oil in rats with subtotal nephrectomy. Kidney Int 1987; 32:700-709.
41. Kelley VE, Sneve S, Musinski S. Increased renal thromboxane production in murine lupus nephritis. J Clin Invest 1986;77: 252.
42. 4 synthesis in immune injured rat glomeruli. J Clin Invest 1988; 81:1945.
43. 4) interactions in the pathophysiology of experimental glomerulonephritis. In: Samuelson B, ed. Advances in prostaglandin, thromboxane, and leukotriene research. New York: Raven Press, 1989;233-236.
44. Baud L, Ardaillou R. Reactive oxygen species: production and role in the kidney. Am J Physiol 1986;251:F765-F776.
45. 4 synthesis: manipulation by (n-6) fatty acid deprivation and cellular origin. J Clin Invest 1988;82:1655.
46. Lianos EA. Synthesis of hydroxyeicosatetraenoic acids and leukotrienes in rat nephrotoxic serum glomerulonephritis. J Clin Invest 1988;82:427.
47. Albrightson CR, Baenziger NL, Needleman P. Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1. J Immunol 1985;135: 1872.
48. Lefkowith JB, Schreiner GF. Essential fatty acid deficiency depletes rat glomeruli of resident macrophages and inhibits angiotensin II-induced eicosanoid synthesis. J Clin Invest 1987;80:947.
49. Diamond JR, Karnovsky MJ. Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 1988;33:917-924.
50. Bang HO, Dyerberg J, Hjorne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976;200:69-73.
51. Dyerberg J, Bang HO. Hemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 1979;2:433-435.
52. Dyerberg J, Bang HO, Stofferson E, et al. Eicosapentaenoic acid and the prevention of thrombosis and atherosclerosis. Lancet 1978;2:117-119.
53. Keane WF, Kasiske BL, O'Donnell MP. Lipids and progressive glomerulosclerosis: a model analogous to atherosclerosis. Am J Nephrol 1988;8:261-271.
54. Wheeler DC, Rair DR, Persaud JW, et al. Effects of dietary fatty acids in an animal model of focal glomerulosclerosis. Kidney Int 1991;39:930-937.
55. Bauer JE. The potential for dietary polyunsaturated fatty acids in domestic animals. Aust Vet 1994;71:342-345.